Anticoagulation Strategies and Determining the Rate of Fatal Intracerebral Hemorrhage Associated With Venovenous Extracorporeal Membrane Oxygenation in Patients With Coronavirus Disease 2019
J Cardiothorac Vasc Anesth
.
2021 May;35(5):1554-1555.
doi: 10.1053/j.jvca.2020.10.039.
Epub 2020 Oct 24.
Authors
Adam Kelly
1
,
Laura Head
1
,
Miguel Garcia
1
,
Tim Hayes
1
,
Michael Charlesworth
1
Affiliation
1
Department of Cardiothoracic Anaesthesia, Critical Care and ECMO, Wythenshawe Hospital, Manchester, UK.
PMID:
33189536
PMCID:
PMC7584492
DOI:
10.1053/j.jvca.2020.10.039
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / adverse effects
COVID-19*
Cerebral Hemorrhage / chemically induced
Extracorporeal Membrane Oxygenation* / adverse effects
Humans
Intracranial Hemorrhages
SARS-CoV-2
Substances
Anticoagulants